Slides
Page 1
Third Quarter 2025 Results November 4, 2025
Page 2
Speakers Samantha Stoddard CFO Bill Christensen CEO
Page 3
Disclosures 3 Certain statements in this presentation, including our guidance and business strategies, are forward- looking statements that involve risk, uncertainty and assumptions, and are based on information as of November 4, 2025. Actual results may differ materially from those set forth in such statements. For a discussion of these risks and uncertainties, you should review our Annual Report on Form 10-K, Form 10-Qs filed in 2025 and our other filings with the U.S. Securities and Exchange Commission. During this presentation, we will discuss certain non-GAAP financial measures including Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted EPS, Free Cash Flow and Net Debt Leverage. A reconciliation of non-GAAP financial measures to their nearest comparable GAAP financial measures is available at the end of this presentation and our earnings release. Due to rounding, numbers presented throughout this presentation may not sum precisely to the totals provided and percentages may not precisely reflect the absolute figures.
Page 4
Third Quarter 2025 Summary ▪ Sales of $809 million ▪ Adjusted EBITDA of $44 million ❑ 5.5% of Sales ▪ Restructuring actions underway Third Quarter 2025 FURTHER MARKET DETERIORATION IMPACTING FY OUTLOOK 4
Page 5
Q3 2025 Financial Results
Page 6
MACROECONOMIC HEADWINDS PERSIST Q3 2025 Financial Summary USD in Millions Net Revenue Core Revenue down (10%) driven by lower volume / mix Adjusted EBITDA Adjusted EBITDA Margin Volume / mix & price / cost challenges driving lower earnings 6 $935 $809 Q3 2024 Q3 2025 -13% $82 $44 Q3 2024 Q3 2025 -46% 8.7% Q3 2024 5.5% Q3 2025 -320 bps
Page 7
Q3 2024 Price Volume / Mix Court-Ordered Towanda Divestiture Foreign Exchange Q3 2025 $935 $5 ($102) ($44) $16 $809 LOWER VOLUME / MIX FROM PERSISTING MARKET HEADWINDS Q3 2025 Revenue Bridge 7 USD in Millions Core Revenue (10%) Note: Amounts do not foot due to rounding
Page 8
LOWER VOLUME / MIX OFFSETS COST SAVINGS MEASURES Q3 2025 Adjusted EBITDA Bridge 8 USD in Millions Q3 2024 Price / Cost Volume / Mix Productivity SG&A / Other Income Court-Ordered Towanda Divestiture Q3 2025 $82 ($11) ($33) $7 $10 ($9) $44 Adj. Margin 8.7% Adj. Margin 5.5% Note: Amounts do not foot due to rounding
Page 9
Q3 2025 Segment Results USD in Millions Segment Highlights ▪ Lower volume / mix - North America down (13%) • Mainly driven by volume - Europe down (6%) • Mainly driven by volume North America Q3 2025 Q3 2024 (Prior Year) Q2 2025 (Previous Quarter) Net Revenue $546 $678 $556 Adjusted EBITDA $38 $75 $35 Adjusted EBITDA margin 6.9% 11.0% 6.3% Europe Q3 2025 Q3 2024 (Prior Year) Q2 2025 (Previous Quarter) Net Revenue $263 $257 $268 Adjusted EBITDA $16 $16 $17 Adjusted EBITDA margin 6.1% 6.3% 6.4% 9
Page 10
Potential Impact of Tariffs USD in Millions – Tariffs as of October 31st China Cambodia, Brazil, all others Tier 2 Suppliers* 1% 7% 5% Percent of Material Costs By Country With Exposure to Tariffs ▪ Annualized tariff impact: ~$45M - Approx. $17M in 2025 8% 5% 87% Tier 1 Tier 2 No Exposure 2024 North America Direct Material Costs Exposed to Tariffs * China accounts for ~65% of Tier 2 exposure 10
Page 11
Outlook
Page 12
Market Outlook North America Europe High Single-Digit Volume Decline Mid Single-Digit Volume Decline New single-family construction Down high single-digits Repair & Remodel Down high single-digits Multi-family & Canada Down 10%+ Residential construction Down mid single-digits Commercial projects Down slightly MIX EXPECTED TO REMAIN AT ENTRY LEVEL PRICE POINT 12
Page 13
SIGNIFICANT LIQUIDITY ON HAND WHILE EXPLORING OPTIONS TO DE -LEVER Updating 2025 Guidance 13 Net Revenue $3.1B to $3.2B Core Revenue Down (10%) to (13%) Adjusted EBITDA $105M to $120M Operating Cash Flow ~($45M) Cap Ex ~$125M Free Cash Flow ~($160M)
Page 14
ADDITIONAL PRICE/COST & PRODUCTIVITY HEADWINDS 2025 Guidance Bridge 14 Adjusted EBITDA; USD in Millions $275 $225 $113 $100 $14 Court- Ordered Towanda Divestiture 2024 EBITDA Without Towanda Market Volume / Mix Pruning / Share Loss from ’24 Price / Cost 2025 EBITDA Guidance Midpoint Other / FXVariable Comp / One Time Reversals TransformationHeadwind Mitigation Base Productivity ($50) ($107) ($50) ($47) ($55) $50 ($17) 2024 EBITDA
Page 15
REDEFINING HOW JELD -WEN COMPETES JELD-WEN Next Steps 15 Strategic Review of Europe Rightsizing North America Simplify Product Portfolio
Page 16
Appendix
Page 17
Guidance Assumptions MARKET IMPACTS OUTWEIGH TRANSFORMATION ACTIONS 17 Market continues to soften Share loss from Midwest customer anniversaries in 2H Price/Cost decline driven by pricing adjustments to maintain volume Base productivity reduction driven by volume deleveraging Transformation/Headwind mitigations on track – – – – +
Page 18
Q3 2025 Net Revenue Walk 18 Q3 2025 JELD-WEN North America Europe Price 1% -% 2% Volume / Mix (11%) (13%) (6%) Core Revenue Growth (10%) (13%) (4%) FX 2% -% 6% Court-Ordered Divestiture (5%) (7%) -% Total (13.4%) (19.4%) 2.6%
Page 19
Balance Sheet and Cash Flow USD in Millions Cash Flow (YTD) Q3 2025 Q3 2024 Net cash (used in) provided by operating activities ($38) $78 Capital Expenditures(1) ($104) ($118) Free Cash Flow(2) ($142) ($40) Balance Sheet September 27, 2025 December 31, 2024 Total Debt $1,183 $1,183 Cash $107 $150 Net Debt(3) $1,076 $1,033 Divided by trailing twelve months Adjusted EBITDA(4) $145 $275 Net Debt Leverage(3) 7.4x 3.8x Liquidity(5) $474 $567 1. Includes purchases of property, equipment, and intangible assets. 2. Free Cash Flow is a financial measure that is not calculated in accordance with GAAP. For a discussion of our presentation of Free Cash Flow, refer to the Q3 2025 earnings release. 3. Net Debt and Net Debt Leverage are financial measures that are not calculated in accordance with GAAP. For a discussion of our presentation of Net Debt Leverage refer to the Q3 2025 earnings release. 4. Trailing twelve months Adjusted EBITDA from continuing operations for both periods. Adjusted EBITDA is a financial measure that is not calculated in accordance with GAAP. For a discussion of our presentation of Adjusted EBITDA, refer to the Q3 2025 earnings release. Additionally, refer to the calculation of trailing twelve months Adjusted EBITDA from continuing operations included later in this presentation. 5. Liquidity includes cash and cash equivalents, as well as availability from undrawn committed credit facilities. 19
Page 20
YTD 2024 Price Volume / Mix Court-Ordered Divestiture Foreign Exchange YTD 2025 $2,880 $18 ($390) ($119) $19 $2,409 LOWER VOLUME / MIX FROM PERSISTING MARKET HEADWINDS Q3 YTD 2025 Revenue Bridge 20 USD in Millions Core Revenue (13%) Note: Amounts do not foot due to rounding
Page 21
LOWER VOLUME/MIX OFFSETS COST SAVINGS MEASURES Q3 YTD 2025 Adjusted EBITDA Bridge 21 USD in Millions YTD 2024 Price / Cost Volume / Mix Productivity SG&A / Other Income Court-Ordered Divestiture YTD 2025 $235 ($26) ($118) $2 $35 ($24) $105 Adj. Margin 8.2% Adj. Margin 4.4% Note: Amounts do not foot due to rounding
Page 22
Adjusted Net (Loss) Income From Continuing Operations Reconciliation 1. Refer to the calculation of Adjusted EBITDA from continuing operations for a discussion of the Special items listed below. 2. Accelerated amortization of an ERP that we are no longer utilizing after we completed our related obligations under the JW Australia Transition Services Agreement during the first quarter of 2024. 3. Except for non-deductible goodwill impairments, adjustments to net (loss) income and net (loss) income per share are tax-effected at the jurisdictional statutory tax rate. 4. Tax special items for the three and nine months ended September 27, 2025 were primarily driven by valuation expense recorded against our U.S. tax attributes of $115.0 million and $129.2 million, respectively. Tax special items for the three and nine months ended September 28, 2024 were primarily driven by tax expense on uncertain tax positions from audits dating back to the year 2015 of $2.4 million and $12.1 million, respectively, and valuation expense recorded against our U.S. tax attributes of $2.6 million and $4.3 million, respectively. Due to rounding, numbers presented may not sum precisely to the totals provided and percentages may not precisely reflect the absolute figures. USD in Millions Three Months Ended Nine Months Ended (amounts in millions) September 27, 2025 September 28, 2024 September 27, 2025 September 28, 2024 Loss from continuing operations, net of tax $ (170.7) $ (73.0) $ (383.1) $ (119.2) Special items:(1) Net legal and professional expenses and settlements 5.8 12.3 26.3 49.8 Goodwill impairment — 63.4 137.7 63.4 Restructuring and asset-related charges, net 8.8 25.5 32.2 60.0 M&A related costs 2.4 3.0 1.9 9.2 Net gain on sale of business, property and equipment — (5.4) (2.8) (8.2) Loss on extinguishment and refinancing of debt — 0.5 0.2 1.9 Share-based compensation expense 4.3 2.5 11.9 12.6 Non-cash foreign exchange transaction/translation gain — (0.4) — (3.1) Accelerated amortization of an ERP system(2) — — — 14.1 Other special items (0.6) 1.7 3.3 9.1 Tax impact of special items(3) 10.5 (7.4) — (31.3) Tax special items(4) 122.3 4.8 137.7 16.8 Adjusted Net (Loss) Income from continuing operations $ (17.3) $ 27.6 $ (34.7) $ 75.4 22
Page 23
Adjusted Net (Loss) Income Per Share From Continuing Operations Reconciliation 1. Refer to the calculation of Adjusted EBITDA from continuing operations for a discussion of the Special items listed below. 2. Accelerated amortization of an ERP that we are no longer utilizing after we completed our related obligations under the JW Australia Transition Services Agreement during the first quarter of 2024. 3. Except for non-deductible goodwill impairments, adjustments to net (loss) income and net (loss) income per share are tax-effected at the jurisdictional statutory tax rate. 4. Tax special items for the three and nine months ended September 27, 2025 were primarily driven by valuation expense recorded against our U.S. tax attributes of $115.0 million and $129.2 million, respectively. Tax special items for the three and nine months ended September 28, 2024 were primarily driven by tax expense on uncertain tax positions from audits dating back to the year 2015 of $2.4 million and $12.1 million, respectively, and valuation expense recorded against our U.S. tax attributes of $2.6 million and $4.3 million, respectively. Due to rounding, numbers presented may not sum precisely to the totals provided and percentages may not precisely reflect the absolute figures. Three Months Ended Nine Months Ended September 27, 2025 September 28, 2024 September 27, 2025 September 28, 2024 Diluted loss per share from continuing operations $ (2.00) $ (0.86) $ (4.50) $ (1.40) Impact of additional dilutive shares on the reported dilutive (loss) income per share — (0.01) — 0.02 Special items:(1) Net legal and professional expenses and settlements 0.07 0.14 0.31 0.58 Goodwill impairment — 0.74 1.62 0.73 Restructuring and asset-related charges, net 0.10 0.30 0.38 0.69 M&A related costs 0.03 0.04 0.02 0.11 Net gain on sale of business, property and equipment — (0.06) (0.03) (0.09) Loss on extinguishment and refinancing of debt — 0.01 — 0.02 Share-based compensation expense 0.05 0.03 0.14 0.15 Non-cash foreign exchange transaction/translation gain — — — (0.04) Accelerated amortization of an ERP system(2) — — — 0.16 Other special items (0.01) 0.02 0.04 0.11 Tax impact of special items(3) 0.12 (0.09) — (0.36) Tax special items(4) 1.43 0.06 1.62 0.19 Adjusted Net (Loss) Income per share from continuing operations $ (0.20) $ 0.32 $ (0.41) $ 0.87 Weighted average diluted shares 85,392,703 85,630,545 85,206,011 86,401,875 Less: Effect of dilutive securities — 1,076,371 — 1,286,805 Weighted average basic shares 85,392,703 84,554,174 85,206,011 85,115,070 23
Page 24
Adjusted EBITDA From Continuing Operations Reconciliation USD in Millions (1) Depreciation and amortization expense includes accelerated amortization of $14.1 million in the nine months ended September 28, 2024, in Corporate and unallocated costs for an ERP system that we are no longer utilizing after we completed our related obligations under the JW Australia Transition Services Agreement during the first quarter of 2024. (2) Net legal and professional expenses and settlements include non-recurring transformation journey expenses of $5.3 million and $24.6 million in the three and nine months ended September 27, 2025, respectively, and $12.0 million and $46.6 million in the three and nine months ended September 28, 2024, respectively. For the three and nine months ended September 27, 2025, these expenses primarily relate to project-based consulting fees that directly support the transformation journey that are not expected to recur in the foreseeable future. These projects include the centralization of human resources processes, North America supply chain network optimization strategy, and other projects related to our transformation journey. For the three and nine months ended September 28, 2024, these expenses primarily relate to the engagement of a transformation consultant for a period spanning from the third quarter of 2023 through April 2025, for which we incurred $7.0 million and $35.4 million in the three and nine months ended September 28, 2024, respectively. Expenses for this transformation consultant’s engagement, which was extended into 2025, included $2.5 million in the nine months ended September 27, 2025, respectively. Additionally, net legal and professional expenses and settlements include $0.4 million in both the three and nine months ended September 27, 2025, and $0.2 million and $2.8 million in the three and nine months ended September 28, 2024, respectively, relating to litigation of historic legal matters. (3) Goodwill impairment consists of goodwill impairment charges associated with our North America reporting unit in 2025 and our Europe reporting unit in 2024 and 2025. (4) Restructuring and asset-related charges, net represents severance, accelerated depreciation and amortization, equipment relocation and other expenses directly incurred as a result of restructuring events. The restructuring charges primarily relate to charges incurred to change the operating structure, eliminate certain roles, and close certain manufacturing facilities in our North America and Europe segments. (5) Product and inventory-related charges related to announced facility closures were detrimental to Adjusted EBITDA from continuing operations. (6) M&A related costs consist of legal and professional expenses related to the court-ordered divestiture of Towanda and other strategic initiatives.(7) Net gain on sale of business, property and equipment in the nine months ended September 27, 2025, primarily relates to the co urt-ordered divestiture of Towanda and the sale of property and equipment in Marion, North Carolina. Net gain on sale of business, property and equipment in the three months ended September 28, 2024, primarily relates to the sale of our business in St. Kitts. Net gain on sale of business, property and equipment in the nine months ended September 28, 2024, primarily relates to the sale of our business in St. Kitts and property in Chile. (8) Loss on extinguishment and refinancing of debt consists of $0.2 million in the nine months ended September 27, 2025, associated with an amendment of our ABL Facility. Loss on extinguishment and refinancing of debt of $0.5 million in the three months ended September 28, 2024, associated with the redemption of the remaining $200.0 million of our 4.63% Senior Notes. Loss on extinguishment and refinancing of debt of $1.9 million in the nine months ended September 28, 2024, associated with an amendment of our Term Loan Facility and redemption of the remaining $200.0 million of our 4.63% Senior Notes. (9) Represents non-cash equity-based compensation expense related to the issuance of share-based awards. (10) Non-cash foreign exchange transaction/translation gain is primarily associated with fair value adjustments of foreign currency derivatives and revaluation of balances denominated in foreign currencies. (11) Other special items not core to ongoing business activity include: in the nine months ended September 28, 2024, a loss of $4.3 million of cumulative foreign currency translation adjustments related to the substantial liquidation of a foreign subsidiary in Chile in our North America segment, a one-time realized foreign currency loss of $1.6 million in our Europe segment related to a cash repatriation event, and ($1.5) million of cash received on an impaired note in Corporate and unallocated costs.Due to rounding, numbers presented may not sum precisely to the totals provided and percentages may not precisely reflect the absolute figures. Three Months Ended Nine Months Ended (amounts in millions) September 27, 2025 September 28, 2024 September 27, 2025 September 28, 2024 Loss from continuing operations, net of tax $ (170.7) $ (73.0) $ (383.1) $ (119.2) Income tax expense 148.7 7.3 145.9 13.4 Depreciation and amortization(1) 28.3 27.9 83.0 97.6 Interest expense, net 17.4 16.3 48.8 48.6 Special items: Net legal and professional expenses and settlements(2) 5.8 12.3 26.3 49.8 Goodwill impairment(3) — 63.4 137.7 63.4 Restructuring and asset-related charges, net(4)(5) 8.8 25.5 32.2 60.0 M&A related costs(6) 2.4 3.0 1.9 9.2 Net gain on sale of business, property and equipment(7) — (5.4) (2.8) (8.2) Loss on extinguishment and refinancing of debt(8) — 0.5 0.2 1.9 Share-based compensation expense(9) 4.3 2.5 11.9 12.6 Non-cash foreign exchange transaction/translation gain(10) — (0.4) — (3.1) Other special items(11) (0.6) 1.7 3.3 9.1 Adjusted EBITDA from continuing operations $ 44.4 $ 81.6 $ 105.3 $ 235.2 24
Page 25
Q3 2025 QTD Segment Adjusted EBITDA From Continuing Operations Reconciliation (1) Refer to the calculation of Adjusted EBITDA from continuing operations for a discussion of the Special items listed above. Due to rounding, numbers presented may not sum precisely to the totals provided and percentages may not precisely reflect the absolute figures. Three Months Ended September 27, 2025 (amounts in millions) North America Europe Corporate and Unallocated Costs Total Consolidated Loss from continuing operations, net of tax $ (137.7) $ — $ (33.0) $ (170.7) Income tax expense (benefit) 151.9 0.4 (3.6) 148.7 Depreciation and amortization 17.3 8.5 2.5 28.3 Interest expense, net 0.2 1.0 16.2 17.4 Special items:(1) Net legal and professional expenses and settlements 1.1 1.5 3.1 5.8 Goodwill impairment — — — — Restructuring and asset-related charges, net 3.9 3.9 1.0 8.8 M&A related costs — — 2.4 2.4 Share-based compensation expense 0.6 0.7 3.0 4.3 Other special items 0.3 — (0.9) (0.6) Adjusted EBITDA from continuing operations $ 37.7 $ 16.0 $ (9.3) $ 44.4 25 USD in Millions
Page 26
(1) Refer to the calculation of Adjusted EBITDA from continuing operations for a discussion of the Special items listed above. Due to rounding, numbers presented may not sum precisely to the totals provided and percentages may not precisely reflect the absolute figures. Three Months Ended September 28, 2024 (amounts in millions) North America Europe Corporate and Unallocated Costs Total Consolidated Income (loss) from continuing operations, net of tax $ 35.8 $ (66.7) $ (42.1) $ (73.0) Income tax expense (benefit) 6.5 2.6 (1.8) 7.3 Depreciation and amortization 18.1 7.9 1.8 27.9 Interest expense (income), net 0.8 — 15.5 16.3 Special items:(1) Net legal and professional expenses and settlements 0.6 1.0 10.7 12.3 Goodwill impairment — 63.4 — 63.4 Restructuring and asset-related charges, net 17.1 7.8 0.6 25.5 M&A related costs — — 3.0 3.0 Net (gain) loss on sale of business, property and equipment (5.3) — (0.2) (5.4) Loss on extinguishment and refinancing of debt — — 0.5 0.5 Share-based compensation expense 0.3 0.3 1.8 2.5 Non-cash foreign exchange transaction/translation loss (gain) 0.1 (0.5) 0.1 (0.4) Other special items 0.7 0.3 0.7 1.7 Adjusted EBITDA from continuing operations $ 74.8 $ 16.3 $ (9.4) $ 81.6 26 Q3 2024 QTD Segment Adjusted EBITDA From Continuing Operations Reconciliation USD in Millions
Page 27
(1) Refer to the calculation of Adjusted EBITDA from continuing operations for a discussion of the Special items listed above. Due to rounding, numbers presented may not sum precisely to the totals provided and percentages may not precisely reflect the absolute figures. Three Months Ended June 28, 2025 (amounts in millions) North America Europe Corporate and Unallocated Costs Total Consolidated Income (loss) from continuing operations, net of tax $ 8.9 $ (4.0) $ (27.3) $ (22.3) Income tax expense (benefit) 5.3 4.5 (13.2) (3.5) Depreciation and amortization 16.8 8.2 2.4 27.4 Interest (income) expense, net (0.6) 1.6 15.5 16.5 Special items:(1) Net legal and professional expenses and settlements 0.8 1.7 6.2 8.6 Restructuring and asset-related charges, net 4.4 4.4 — 8.8 M&A related costs — — 0.1 0.1 Net gain on sale of business, property and equipment (2.2) — — (2.2) Share-based compensation expense 1.0 0.6 2.9 4.4 Other special items 0.3 0.1 0.7 1.1 Adjusted EBITDA from continuing operations $ 34.7 $ 17.0 $ (12.8) $ 39.0 27 USD in Millions Q2 2025 QTD Segment Adjusted EBITDA From Continuing Operations Reconciliation
Page 28
(1) Refer to the calculation of Adjusted EBITDA from continuing operations for a discussion of the Special items listed above. Due to rounding, numbers presented may not sum precisely to the totals provided and percentages may not precisely reflect the absolute figures. Nine Months Ended September 27, 2025 (amounts in millions) North America Europe Corporate and Unallocated Costs Total Consolidated Loss from continuing operations, net of tax $ (290.0) $ (7.4) $ (85.7) $ (383.1) Income tax expense (benefit) 166.5 6.8 (27.5) 145.9 Depreciation and amortization 51.4 24.3 7.4 83.0 Interest (income) expense, net (1.0) 2.6 47.2 48.8 Special items:(1) Net legal and professional expenses and settlements 2.6 4.3 19.4 26.3 Goodwill impairment 137.7 — — 137.7 Restructuring and asset-related charges, net 19.0 11.5 1.7 32.2 M&A related costs — — 1.9 1.9 Net gain on sale of business, property and equipment (2.8) — — (2.8) Loss on extinguishment and refinancing of debt — — 0.2 0.2 Share-based compensation expense 2.1 1.7 8.1 11.9 Other special items 2.3 0.1 0.9 3.3 Adjusted EBITDA from continuing operations $ 87.9 $ 43.7 $ (26.4) $ 105.3 28 USD in Millions Q3 2025 YTD Segment Adjusted EBITDA From Continuing Operations Reconciliation
Page 29
(1) Corporate and unallocated depreciation and amortization expense in the nine months ended September 28, 2024, includes accelerated amortization of $14.1 million for an ERP system that we are no longer utilizing after we completed our related obligations under the JW Australia Transition Services Agreement. (2) Refer to the calculation of Adjusted EBITDA from continuing operations for a discussion of the Special items listed above. Due to rounding, numbers presented may not sum precisely to the totals provided and percentages may not precisely reflect the absolute figures. Nine Months Ended September 28, 2024 (amounts in millions) North America Europe Corporate and Unallocated Costs Total Consolidated Income (loss) from continuing operations, net of tax $ 82.8 $ (71.7) $ (130.3) $ (119.2) Income tax expense (benefit) 26.8 15.8 (29.2) 13.4 Depreciation and amortization(1) 55.0 22.9 19.6 97.6 Interest expense, net 2.1 0.9 45.5 48.6 Special items:(2) Net legal and professional expenses and settlements 2.3 2.4 45.1 49.8 Goodwill impairment — 63.4 — 63.4 Restructuring and asset-related charges, net 40.2 18.4 1.4 60.0 M&A related costs — — 9.2 9.2 Net gain on sale of business, property and equipment (7.8) (0.2) (0.2) (8.2) Loss on extinguishment and refinancing of debt — — 1.9 1.9 Share-based compensation expense 2.6 1.0 9.0 12.6 Non-cash foreign exchange transaction/translation loss (gain) 0.3 (3.8) 0.4 (3.1) Other special items 7.2 1.9 — 9.1 Adjusted EBITDA from continuing operations $ 211.6 $ 51.2 $ (27.6) $ 235.2 29 USD in Millions Q3 2024 YTD Segment Adjusted EBITDA From Continuing Operations Reconciliation
Page 30
(1) Refer to the calculation of Adjusted EBITDA from continuing operations for a discussion of the Special items listed above. Due to rounding, numbers presented may not sum precisely to the totals provided and percentages may not precisely reflect the absolute figures. Trailing Twelve Months Ended (amounts in millions) September 27, 2025 December 31, 2024 Loss from continuing operations, net of tax $ (451.5) $ (187.6) Income tax expense 149.2 16.8 Depreciation and amortization 111.3 125.8 Interest expense, net 67.5 67.2 Special items:(1) Net legal and professional expenses and settlements 39.2 62.7 Goodwill impairment 169.1 94.8 Restructuring and asset-related charges, net 40.3 68.1 M&A related costs 7.9 15.3 Net gain on sale of business, property and equipment (8.4) (13.8) Loss on extinguishment and refinancing of debt 0.2 1.9 Share-based compensation expense 14.8 15.5 Non-cash foreign exchange transaction/translation gain — (3.1) Other special items 5.8 11.6 Adjusted EBITDA from continuing operations $ 145.4 $ 275.2 30 Q3 2025 TTM Adjusted EBITDA From Continuing Operations Reconciliation USD in Millions